Perspective on I-O failures

Robert A. Figlin, MD, talks about the best actions to take if newly diagnosed advanced renal cell carcinoma (RCC) patients receive nivolumab & ipilimumab but continues to progress at ASCO 2018. Author: obr Added: 07/17/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts